phentolamine and Injury, Ischemia-Reperfusion studies

phentolamine and Injury, Ischemia-Reperfusion

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Research Excerpts

Excerpt	Relevance	Reference
" This selective localization of Annexin A5 was reduced by ischemic preconditioning (10 minutes of ischemia plus reperfusion before ischemic exercise) or by infusion of adenosine into the brachial artery to 6+/-1% and 10+/-3%, respectively (P<0."	3.73	Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. ( Boerman, OC; Oyen, WJ; Ramakers, BP; Riksen, NP; Rongen, GA; Smits, P; Steinmetz, N, 2005)
"Here, mice subjected to renal ischemia reperfusion injury had significantly lower levels of renalase in the plasma and kidney compared with sham-operated mice."	1.39	Renalase protects against ischemic AKI. ( Baroni, S; D'Agati, VD; Desir, GV; Kim, JY; Kim, M; Lee, HT; Tang, L; Wang, P, 2013)

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (33.33)	18.2507
2000's	3 (50.00)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

2 (33.33)

18.2507

2000's

3 (50.00)

29.6817

2010's

1 (16.67)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Moffatt-Bruce, S	1
Lee, HT	1
Kim, JY	1
Kim, M	1
Wang, P	1
Tang, L	1
Baroni, S	1
D'Agati, VD	1
Desir, GV	1
Rongen, GA	1
Oyen, WJ	1
Ramakers, BP	1
Riksen, NP	1
Boerman, OC	1
Steinmetz, N	1
Smits, P	1
Zhang, YM	1
Wei, EQ	1
Hu, X	1
Xu, M	1
Shi, Y	1
Zhang, JF	1
Barbieri, A	2
Zonta, F	2
Saracino, ML	1
Dondi, G	1
Frattini, P	2
Lucchelli, A	1
Santagostino, M	1
D'Agostino, G	1
Maestri, MO	2
Zonta, A	2
Pettenazza, P	1
Gaspari, A	1

Studies

Moffatt-Bruce, S

Lee, HT

Kim, JY

Kim, M

Wang, P

Tang, L

Baroni, S

D'Agati, VD

Desir, GV

Rongen, GA

Oyen, WJ

Ramakers, BP

Riksen, NP

Boerman, OC

Steinmetz, N

Smits, P

Zhang, YM

Wei, EQ

Hu, X

Xu, M

Shi, Y

Zhang, JF

Barbieri, A

Zonta, F

Saracino, ML

Dondi, G

Frattini, P

Lucchelli, A

Santagostino, M

D'Agostino, G

Maestri, MO

Zonta, A

Pettenazza, P

Gaspari, A

Clinical Trials (9)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Caffeine Reduces Acute Ischemic Preconditioning[NCT00184912]		24 participants	Interventional	2003-09-30	Completed
The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy. A Double Blind Placebo- Controlled Cross-over Study in Subjects With the Metabolic Syndrome[NCT00405015]	Phase 2	13 participants (Actual)	Interventional	2007-04-30	Completed
Opioid Induced Acute Preconditioning[NCT00184938]		40 participants (Anticipated)	Interventional	2005-01-31	Suspended
Does Rosuvastatin Reduce Ischemia/Reperfusion Injury in Humans In-Vivo? A Randomized Double Blind Placebo Controlled Trial[NCT00315510]	Phase 2	20 participants	Interventional	2006-04-30	Completed
Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?[NCT00430170]	Phase 4	20 participants (Actual)	Interventional	2007-01-31	Completed
Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?[NCT00441597]	Phase 4	30 participants (Anticipated)	Interventional	2007-02-28	Completed
Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise[NCT00441714]		0 participants (Actual)	Interventional	2007-10-31	Withdrawn (stopped due to new insights have let us to expect marginal annexin targeting with a 10 minutes delay between reperfusion and administration of Annexin A5)
Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?[NCT00457652]	Phase 4	24 participants (Actual)	Interventional	2007-06-30	Completed
Pilot Study for the Development of Transient Forearm Endothelial Dysfunction[NCT00453531]	Phase 1/Phase 2	6 participants (Actual)	Interventional	2007-03-26	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Caffeine Reduces Acute Ischemic Preconditioning[NCT00184912]

24 participants

Interventional

2003-09-30

Completed

The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy. A Double Blind Placebo- Controlled Cross-over Study in Subjects With the Metabolic Syndrome[NCT00405015]

Phase 2

13 participants (Actual)

Interventional

2007-04-30

Completed

Opioid Induced Acute Preconditioning[NCT00184938]

40 participants (Anticipated)

Interventional

2005-01-31

Suspended

Does Rosuvastatin Reduce Ischemia/Reperfusion Injury in Humans In-Vivo? A Randomized Double Blind Placebo Controlled Trial[NCT00315510]

Phase 2

20 participants

Interventional

2006-04-30

Completed

Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?[NCT00430170]

Phase 4

20 participants (Actual)

Interventional

2007-01-31

Completed

Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?[NCT00441597]

Phase 4

30 participants (Anticipated)

Interventional

2007-02-28

Completed

Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise[NCT00441714]

0 participants (Actual)

Interventional

2007-10-31

Withdrawn (stopped due to new insights have let us to expect marginal annexin targeting with a 10 minutes delay between reperfusion and administration of Annexin A5)

Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?[NCT00457652]

Phase 4

24 participants (Actual)

Interventional

2007-06-30

Completed

Pilot Study for the Development of Transient Forearm Endothelial Dysfunction[NCT00453531]

Phase 1/Phase 2

6 participants (Actual)

Interventional

2007-03-26

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

6 other studies available for phentolamine and Injury, Ischemia-Reperfusion

Article	Year
Invited commentary. The Annals of thoracic surgery, 2009, Volume: 88, Issue:3 Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Extravascular Lung Water; Graft Survival; Immunosuppres	2009
Renalase protects against ischemic AKI. Journal of the American Society of Nephrology : JASN, 2013, Volume: 24, Issue:3 Topics: Acute Kidney Injury; Adrenergic alpha-Antagonists; Animals; Apoptosis; Gene Expression; Humans; Infl	2013
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo	2005
Administration of angiotensin II in the paraventricular nucleus protects gastric mucosa from ischemia-reperfusion injury. Brain research, 2008, May-30, Volume: 1212 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Disease M	2008
Evaluation of the reperfusion syndrome after liver ischemia in the rat. The Journal of surgical research, 1996, Volume: 62, Issue:2 Topics: Animals; Dopamine; Epinephrine; Hypertension, Pulmonary; Ischemia; Liver; Male; Norepinephrine; Phen	1996
Liver ischemia modifies the concentration of plasmatic catecholamines after reperfusion in the rat. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1999, Volume: 31, Issue:3 Topics: Animals; Catecholamines; Dopamine; Epinephrine; In Vitro Techniques; Ischemia; Liver; Male; Muscle C	1999

Article

Year

Invited commentary.

The Annals of thoracic surgery, 2009, Volume: 88, Issue:3

Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Extravascular Lung Water; Graft Survival; Immunosuppres

2009

Renalase protects against ischemic AKI.

Journal of the American Society of Nephrology : JASN, 2013, Volume: 24, Issue:3

Topics: Acute Kidney Injury; Adrenergic alpha-Antagonists; Animals; Apoptosis; Gene Expression; Humans; Infl

2013

Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.